Cita APA (7a ed.)
Li, H., Jia, M., Zhao-Long, Q., Lu, C., Chu, W., Zhang, Z., . . . Fu, L. (Dec 2024). Discovery of novel 2,4-diarylaminopyrimidine hydrazone derivatives as potent anti-thyroid cancer agents capable of inhibiting FAK. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2024.2423875
Cita Chicago Style (17a ed.)
Li, Hongting, et al. "Discovery of Novel 2,4-diarylaminopyrimidine Hydrazone Derivatives as Potent Anti-thyroid Cancer Agents Capable of Inhibiting FAK." Journal of Enzyme Inhibition and Medicinal Chemistry Dec 2024. https://doi.org/10.1080/14756366.2024.2423875.
Cita MLA (9a ed.)
Li, Hongting, et al. "Discovery of Novel 2,4-diarylaminopyrimidine Hydrazone Derivatives as Potent Anti-thyroid Cancer Agents Capable of Inhibiting FAK." Journal of Enzyme Inhibition and Medicinal Chemistry, Dec 2024, https://doi.org/10.1080/14756366.2024.2423875.
Precaución: Estas citas no son 100% exactas.